Marseilles
France
11
2015-10-22
11
2018-08-28
These are the the leading inventors for applications assigned to Innate Pharma, S.A.:
Innate Pharma, S.A. based in Marseilles, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
#2 | 2015-07-09 β Patent 10,577,416 granted on 2020-03-03Mica binding agents
#3 | 2015-05-07 β Patent 10,160,810 granted on 2018-12-25Monoclonal antibodies against NKG2A
#4 | 2012-12-27 β Patent 9,067,997 granted on 2015-06-30Anti-KIR antibodies for the treatment of inflammatory and autoimmune disorders
#5 | 2011-01-13 β Patent 9,090,876 granted on 2015-07-28Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
#6 | 2010-08-12 β Patent 8,017,596 granted on 2011-09-13Phosphonates useful as modulators of T-Ξ³-9-Ξ΄-2 activity
#7 | 2009-08-20 β Patent 8,993,319 granted on 2015-03-31Monoclonal antibodies against NKG2A
#8 | 2008-11-06 β Patent 9,447,185 granted on 2016-09-20Compositions and methods for treating proliferative disorders
#9 | 2008-04-03 β Patent 7,732,131 granted on 2010-06-08Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor
#10 | 2005-07-21 β Patent 7,138,243 granted on 2006-11-21NTB-A, a surface molecule involved in natural killer cells activity
#11 | 2005-02-17 β Patent 7,803,376 granted on 2010-09-28Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
Also check out Innate Pharma S.A.'s (Marseilles, France) applicant profile with 3 patent applications submitted.
368423 β